Bone Cancer Treatment in India 2026: Osteosarcoma, Limb Salvage Surgery and Costs for International Patients
Bone Cancer Treatment in India 2026: Osteosarcoma, Limb Salvage Surgery and Costs for International Patients
Bone cancer — though less common than other malignancies — is one of the most challenging diagnoses a patient can receive. Osteosarcoma and Ewing's sarcoma, the two most common primary bone cancers, predominantly affect children, adolescents, and young adults. Getting the right treatment matters enormously: the difference between limb-saving surgery and amputation, between cure and recurrence, is often a question of where and by whom the treatment is delivered.
India's top orthopaedic oncology centres offer world-class bone tumour surgery, internationally matched chemotherapy protocols, and 3D-printed custom implants — at costs that make it accessible for African families who would otherwise have no option beyond amputation or no treatment at all.
Types of Primary Bone Cancer Treated in India
Osteosarcoma: The most common primary bone cancer. Usually arises in the metaphysis (growth plate region) of long bones — distal femur (lower thigh), proximal tibia (upper shin), proximal humerus (upper arm). Peak incidence in the 10 to 20 year age group, with a second smaller peak in adults over 50. Aggressive tumour that requires combination of chemotherapy and surgery.
Ewing's Sarcoma: Second most common primary bone tumour. Can arise in bone or soft tissue. Common sites include the pelvis, femur, tibia, and ribs. Affects children and young adults. Treated with a combination of chemotherapy, surgery, and sometimes radiotherapy.
Chondrosarcoma: Arises from cartilage-forming cells. More common in adults (30 to 60 years). Less responsive to chemotherapy — surgery is the primary treatment. Slower growing than osteosarcoma.
Giant Cell Tumour of Bone (GCTB): Technically benign but locally aggressive. Can transform to malignancy. Often affects the distal femur and proximal tibia in young adults. Treated with curettage and bone grafting, or resection and reconstruction for high-grade/recurrent cases. Denosumab (RANKL inhibitor) is used for unresectable cases.
The Treatment Approach for Osteosarcoma in India
Modern osteosarcoma treatment follows a three-phase approach that India's specialist centres follow precisely:
Phase 1 — Neoadjuvant Chemotherapy (8–10 weeks):
MAP protocol (Methotrexate, Adriamycin/doxorubicin, Cisplatin) or equivalent. Given before surgery to shrink the tumour and target micrometastases. Tumour response to chemotherapy (histological necrosis at surgery) is one of the most important prognostic factors.
Phase 2 — Surgery:
Limb salvage or amputation. Performed by an orthopaedic oncology specialist.
Phase 3 — Adjuvant Chemotherapy (18–28 weeks):
Same or modified protocol, tailored to the tumour's response to neoadjuvant treatment.
Total treatment duration: 9 to 12 months.
Limb Salvage Surgery: What It Is and Why It Matters
Limb salvage surgery means removing the bone tumour with wide margins while preserving the limb — avoiding amputation. In appropriately selected patients, it achieves equivalent survival rates to amputation while dramatically improving functional outcome and quality of life.
India's top orthopaedic oncology centres achieve limb salvage in 80 to 90 percent of appropriate cases — comparable to the best Western centres.
Types of reconstruction after bone tumour resection:
| Reconstruction Method | Best For | Longevity |
|---|---|---|
| Megaprosthesis (endoprosthesis) | Most cases, immediate function | 15–20+ years with good care |
| Modular tumour prosthesis | Skeletally immature children | Expandable as child grows |
| Allograft (cadaver bone) | Selected cases | Good long-term if heals |
| Allograft-prosthesis composite | Complex defects | Durable |
| 3D-printed custom implant | Pelvis, unusual geometry | Emerging gold standard |
| Vascularised fibula autograft | Children, forearm | Grows with patient |
3D-Printed Custom Implants: India's Cutting Edge
One of the most exciting developments in orthopaedic oncology in India is the use of 3D-printed titanium implants for pelvic and complex bone reconstruction. India's leading centres including AIIMS Delhi, Tata Memorial Hospital, and Manipal have 3D printing capabilities that allow:
- Custom implants designed to the exact geometry of the resected bone
- Porous surfaces that encourage bone ingrowth
- Faster surgery through precise pre-operative planning
- Better functional outcomes in complex pelvic and shoulder girdle tumours
This technology, which would cost USD 50,000 to 80,000 for the implant alone in the USA, is being made available in India at a fraction of that cost.
Costs of Bone Cancer Treatment in India
| Component | Cost (USD) |
|---|---|
| Pre-treatment staging (MRI, PET-CT, biopsy) | USD 800–1,500 |
| Neoadjuvant chemotherapy (MAP, per cycle) | USD 1,500–2,500 |
| Limb salvage surgery with megaprosthesis | USD 8,000–15,000 |
| 3D-printed custom pelvic implant | USD 12,000–20,000 |
| Amputation (if required) | USD 3,000–6,000 |
| Adjuvant chemotherapy (full course) | USD 15,000–30,000 |
| Post-operative rehabilitation | USD 1,000–3,000 |
Total treatment cost for osteosarcoma in India (including surgery and all chemotherapy): approximately USD 30,000 to 60,000.
The equivalent treatment in the USA would cost USD 200,000 to 500,000.
Which Indian Hospitals Specialise in Bone Cancer?
Tata Memorial Hospital, Mumbai: India's national cancer centre and highest-volume bone tumour centre. Handles the most complex cases including pelvic sarcomas and recurrent disease. India's benchmark for orthopaedic oncology outcomes.
AIIMS New Delhi: Leading academic centre with experienced orthopaedic oncology surgeons. First hospital in India to develop 3D-printed implant programmes for bone tumour reconstruction.
Manipal Comprehensive Cancer Centre, Bangalore: Strong orthopaedic oncology team with multidisciplinary sarcoma board. Good for patients in South India.
Apollo Hospitals, Chennai and Hyderabad: Full oncology infrastructure including orthopaedic oncology, medical oncology, and radiation oncology under one roof.
Kokilaben Dhirubhai Ambani Hospital, Mumbai: Robotic and minimally invasive orthopaedic surgery capabilities with growing sarcoma programme.
Survival Rates and Outcomes
For localised osteosarcoma treated with appropriate chemotherapy and limb salvage surgery, 5-year overall survival at major Indian centres is 60 to 70 percent — in line with published international data from US, European, and Japanese centres. The most important predictor of outcome is adequate surgical margins (wide excision with no tumour at the edge) combined with good histological response to chemotherapy.
For Ewing's sarcoma with localised disease, 5-year survival ranges from 65 to 75 percent with multimodal treatment.
Getting Treatment in India for Bone Cancer
If you or your child has been diagnosed with osteosarcoma or Ewing's sarcoma, speed matters. These tumours can grow and spread quickly. Contact Arodya immediately — we can fast-track your referral to a bone tumour specialist, coordinate imaging review, and arrange your India trip within 1 to 2 weeks.
Bring all existing imaging (X-rays, MRI, CT scans) on a USB drive or CD, plus any biopsy reports. If biopsy has not yet been performed, it may be more appropriate to have it done in India where the treating surgeon can ensure adequate tissue is taken with correct technique.
For more on cancer treatment costs in India, read our detailed cost comparison: India vs USA vs UK. For information on chemotherapy costs specifically, see our chemotherapy cost guide for India.
